All News
Madan et al. Ferritin levels more than 7511 and ferritin/ CRP levels more than 204.5 was associated with higher mortality in Macrophage Activation Syndrome @RheumNow #ACR22 Abstr#0825 https://t.co/jL58oCCEWa https://t.co/9V4PW49EyC
Richard Conway RichardPAConway ( View Tweet)
Ma et al. Calprotectin differentiates remission and low disease activity in RA. @RheumNow #ACR22 Abstr#0884 https://t.co/z9oeKPLq5z https://t.co/YFkIBEqT0c
Richard Conway RichardPAConway ( View Tweet)
Sarilumab in GC resistant PMR
🔥SAPHYR🔥
👉Arm 1- sar 200mg Q2W + 14wk GC
👉 Arm 2- PBO Q2W + 52wk GC
🌟RESULTS🌟
💪🏻 Arm 1 - PMR symp + signs ⬇️ wk 2 with continued improvement until wk 52
🌟Arm 1- ⬇️ chance flare post achieving remission
#ACR22 @RheumNow https://t.co/tXQuuoAelP
Patricia Harkins DrTrishHarkins ( View Tweet)
CLE to SLE transition occurred more frequently in pts aged 40 and younger, w/in the first 10 years of dx, and those with SCLE. Abs 0338 #ACR22 @RheumNow https://t.co/XxHjkNL5Hf https://t.co/1WtgmVM7Iz
Dr. Rachel Tate uptoTate ( View Tweet)
Saxena et al Zetomipzomib, a selective immunoproteasome inhibitor in lupus nephritis. Phase 2 study. UPCR=<0.5 achieved 64.7% week 37, pred=<10mg/day 82.4% week 13. @RheumNow #ACR22 Abstr#0992 https://t.co/askpmqsYYG https://t.co/cKoR0bgtWt
Richard Conway RichardPAConway ( View Tweet)
Wallace @zach_wallace_md et al. IgG4-RD in USA. Incidence 1.2/100,000, prevalence 2.8/100,000. Pancreas (43.0%), biliary tract (30.6%), salivary glands (11.7%), retroperitoneum (5.0%). HR 2.51 for mortality in IgG4-RD. @RheumNow #ACR22 Abstr#0713 https://t.co/IpjSKxmHQN
Richard Conway RichardPAConway ( View Tweet)
Opioid use in adults with PsA and AS
Abstract #0402 @RheumNow #ACR22
✋828 PsA patients ➡️ 21% used opioids
🦴 334 AS patients ➡️ 27% used opioids
💊Opioid users had more comorbidities, more medical visits, worse disease activity, and higher prevalence of 🚬
Catherine Sims, MD DrCassySims ( View Tweet)
Manansala et al. Baseline lymphopenia negatively predicts disease severity in sarcoid. It is protective for decline in FBC. @RheumNow #ACR22 Abstr#0830 https://t.co/Q4fE9LoG9L https://t.co/Tt1PyYLfWu
Richard Conway RichardPAConway ( View Tweet)
Ross et al. Comorbid liver disease significantly attenuates CRP rise with disease flare. Increased BMI increases CRP rise. @RheumNow #ACR22 Abstr#0811 https://t.co/O3PsDfbCMV https://t.co/9xAqWTJqkf
Richard Conway RichardPAConway ( View Tweet)
Fat and bone health are related via adipokines (fat hormones).
Data from VA registry of RA pts:
clear relationship between elevated adipokines & osteoporotic fracture risk.
This is why body fat should be a target for osteoporosis management
ABST0889 @PennRheum #ACR22 @RheumNow https://t.co/BoP8d4sooZ
David Liew drdavidliew ( View Tweet)
Vural et al Rituximab biosimilar switch in GPA. Essentially it is the same. @RheumNow #ACR22 Abstr#1072 https://t.co/OBOMz35soX https://t.co/dPdcWQmBzd
Richard Conway RichardPAConway ( View Tweet)
Soussi et al. Over last 20 years, 5-year all-cause morality decreased in RA and controls in Danish study. But to greater extent in RA, narrowing mortality gap. @RheumNow #ACR22 Abstr#0711 https://t.co/JRh37u3uGm https://t.co/bA3Y5FLcRZ
Richard Conway RichardPAConway ( View Tweet)
Have you heard of MyPROSLE (available at https://t.co/a4zlBtwaaC)? Abs 0329 details MyPROSLE's molecular characterization of individual SLE pts and it's extraction of key molecular information to support more precise therapeutic decisions. #ACR22 @RheumNow https://t.co/FslQCVvptw https://t.co/NNlgZvllPC
Links:
Dr. Rachel Tate uptoTate ( View Tweet)
🔥ignite session🔥
❓Vessel wall MRI superior to TA-US in c-GCA❓
🔥In c-GCA vessel wall MRI examines beyond the temporal arteries -
✅more 🧠 cranial arteries, including occipital arteries and the all important 👁 orbital structures
Abst#0473
#ACR22 @RheumNow https://t.co/z8hYmqc95I
Patricia Harkins DrTrishHarkins ( View Tweet)
Carter et al. Case series showing rapid effect of anifrolumab in refractory discoid lupus and SCLE. @RheumNow #ACR22 Abstr#0974 https://t.co/Od1PXzJKQh https://t.co/Hk8mrblGMX
Richard Conway RichardPAConway ( View Tweet)
Ab2126 #ACR22 Risankizumab on Enthesitis/Dactylitis
KEEPsAKE 1&2 - RZB v PBO
1407 pts -baseline 63% enth, 28% dact, 20% both
Wk 24: 14% decr. enthesitis, 17% decr dact, 13% decr both
Mean time to resolution decreased
Results maintained through wk 52
@RheumNow https://t.co/RBubeuJoh8
Eric Dein ericdeinmd ( View Tweet)
Frey @CaoilfhionnMD @JuliePaikMD et al. Increasing duration of hold of MMF (esp >=10 days) increased response to SARS-CoV-2 vaccine. No difference in disease flare rates. @RheumNow #ACR22 Abstr#0797 https://t.co/5nxo2nLg80 https://t.co/sx1Roxngx9
Richard Conway RichardPAConway ( View Tweet)
In this prospective cohort study by Dr Jacquez, there was a statistically significant inverse assoc bet. average yearly HCQ dose and overall damage accrual 👇
Reassuring data.
☝️HCQ consistently proves to be a beneficial drug for #lupus
#ACR22 @Rheumnow ABST#0982 @rheumarhyme https://t.co/nWHS9JtEsH
sheila RHEUMarampa ( View Tweet)
Pedersen @EBRheum et al. 203 RCTs, 35 (17.2%) remained unpublished more than 30 months after completion. Cited reasons: ongoing preparation/review of paper (50%), sponsor/funder problems (40%), unimportant/negative result (20%).@RheumNow #ACR22 Abstr#0827 https://t.co/V2a48iiAcn https://t.co/FLqQhjvlOx
Richard Conway RichardPAConway ( View Tweet)
#ACR22 Abstr#0825 Can we identify predictors of deaths in patients presenting with Macrophage Activation Syndrome? A cohort study (N=43) reported MAS was mostly secondary to disease. 10/43 died. Super high Ferritin and raised Ferritin/CRP ratio were assoc with deaths @RheumNow https://t.co/JCH30pi4Vf
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
